Medical School · Year 1 · Cardiovascular · includes a quiz and discussion video

Lecture 5: Cardiac Output Regulation

Unit 1.7: Cardiovascular System

Learning Objectives

By the end of this lecture, students will be able to:

1. Define cardiac output and describe methods of measurement
2. Explain the Frank-Starling mechanism and its physiological significance
3. Describe the factors affecting preload, afterload, and contractility
4. Explain neural and hormonal regulation of cardiac output
5. Describe the venous return curve and its interaction with cardiac function
6. Apply cardiac output concepts to exercise and pathological states

Cardiac Output Fundamentals

Cardiac output represents the total volume of blood pumped by the heart per unit time and serves as the primary measure of cardiovascular performance. It is calculated as the product of heart rate and stroke volume. At rest, with a heart rate of approximately 70 beats per minute and stroke volume of 70 milliliters, cardiac output is approximately 5 liters per minute—roughly equal to the entire blood volume circulating once per minute.

Stroke volume is the volume of blood ejected by the ventricle with each heartbeat, calculated as end-diastolic volume minus end-systolic volume. Normal stroke volume at rest is approximately 70 milliliters, rising to as much as 120 milliliters during maximal exercise in trained individuals.

The cardiac index normalizes cardiac output to body surface area, allowing comparison between individuals of different sizes. Normal cardiac index ranges from 2.5 to 4 liters per minute per square meter of body surface area.

Ejection fraction represents the proportion of end-diastolic volume that is ejected with each beat, calculated as stroke volume divided by end-diastolic volume and expressed as a percentage. Normal ejection fraction ranges from 55 to 70 percent. Values below 40 percent indicate significant systolic dysfunction.

Cardiac reserve describes the difference between resting cardiac output and maximum cardiac output. A healthy young adult can increase cardiac output from 5 liters per minute at rest to 20 to 25 liters per minute during maximal exercise—a fourfold to fivefold increase. This reserve reflects the heart's ability to meet increased metabolic demands and is substantially reduced in heart failure.

<image>Panel A: Central equation CO = HR x SV with HR and SV shown as adjustable factors. Panel B: Bar graph comparing resting values (HR = 70 bpm, SV = 70 mL, CO = 5 L/min) to maximal exercise values (HR = 200 bpm, SV = 120 mL, CO = 24 L/min). Panel C: Ejection fraction calculation with ventricular volumes shown as cylindrical chambers (EDV 120 mL minus ESV 50 mL equals SV 70 mL, EF = 58%). Panel D: Cardiac reserve illustrated as difference between resting and maximum CO on vertical scale.</image>

Measurement of Cardiac Output

Several methods allow measurement of cardiac output, each with advantages and limitations in different clinical settings.

The Fick principle, developed by Adolf Fick in 1870, remains the gold standard for cardiac output measurement. It is based on the principle of conservation of mass: the amount of oxygen consumed by the body per minute must equal the amount of oxygen delivered by the blood minus the amount returning to the heart. The equation is: cardiac output equals oxygen consumption divided by the arteriovenous oxygen difference. With a typical oxygen consumption of 250 milliliters per minute and arterial oxygen content of 200 milliliters per liter minus mixed venous oxygen content of 150 milliliters per liter (an arteriovenous difference of 50 milliliters per liter), cardiac output calculates to 5 liters per minute. This method requires measurement of oxygen consumption (usually by analyzing inspired and expired gases) and sampling of arterial and mixed venous blood.

Thermodilution is the most commonly used invasive method in clinical practice. A known volume of cold saline is injected into the right atrium through a central venous catheter, and the temperature change is measured downstream in the pulmonary artery by a thermistor-equipped Swan-Ganz catheter. The temperature change is inversely proportional to cardiac output—higher cardiac output causes greater dilution and less temperature change. The area under the temperature-time curve, analyzed using the Stewart-Hamilton equation, yields cardiac output.

Echocardiographic methods provide noninvasive cardiac output measurement. Doppler echocardiography measures blood flow velocity across the aortic valve, and this velocity-time integral (VTI) is multiplied by the cross-sectional area of the aortic valve annulus to calculate stroke volume. Cardiac output is then stroke volume times heart rate. While less invasive than catheter-based methods, accuracy depends on precise measurement of the valve area and assumes uniform velocity across the valve.

<image>Panel A: Fick Principle showing oxygen consumption measurement with spirometer, arterial sampling (CaO2 = 200 mL/L), pulmonary artery sampling (CvO2 = 150 mL/L), and calculation CO = 250 mL/min divided by 50 mL/L = 5 L/min. Panel B: Thermodilution with Swan-Ganz catheter showing cold saline injection in right atrium, thermistor in pulmonary artery, and temperature-time curve with area inversely related to CO. Panel C: Echocardiography Doppler image of left ventricular outflow tract with velocity envelope and VTI outlined. Panel D: Calculation showing SV = VTI x CSA followed by CO = SV x HR.</image>

The Frank-Starling Mechanism

The Frank-Starling mechanism is the fundamental intrinsic property by which the heart automatically adjusts its output to match venous return. Named for Otto Frank and Ernest Starling, who independently characterized it in the late 19th and early 20th centuries, this mechanism ensures that the heart pumps out whatever blood flows into it.

The principle states that increased end-diastolic volume (preload) leads to increased stroke volume. When more blood returns to the heart, the ventricle fills to a larger volume, stretching the sarcomeres of the cardiac muscle fibers. This stretch, within physiological limits, increases the force of the subsequent contraction.

The mechanism operates through several molecular events. First, stretching the sarcomeres toward their optimal length of approximately 2.2 micrometers improves the overlap between actin and myosin filaments, allowing more cross-bridges to form. Second, stretch increases the sensitivity of the contractile apparatus to calcium, so that the same calcium transient produces more force. Third, stretch may activate length-dependent calcium influx through stretch-sensitive channels.

The Frank-Starling mechanism serves several critical physiological functions. It matches the outputs of the right and left ventricles, preventing pulmonary or systemic congestion. If the right ventricle momentarily pumps more blood into the pulmonary circulation, the left ventricle receives more blood, stretches more, and automatically increases its output to match. The mechanism also allows the heart to adapt to changes in venous return, such as during postural changes or changes in blood volume.

The Frank-Starling curve plots stroke volume (or cardiac output) on the vertical axis against preload (measured as end-diastolic volume, end-diastolic pressure, or pulmonary capillary wedge pressure) on the horizontal axis. The curve shows that stroke volume increases steeply with increasing preload at lower volumes, then plateaus at higher preloads. Beyond the plateau, excessive stretch can actually reduce contractile force (the descending limb), though this is rarely reached in the intact heart.

<image>Panel A: Frank-Starling curve with stroke volume on y-axis and end-diastolic volume on x-axis showing ascending limb reaching plateau, with three superimposed curves for normal, enhanced contractility (sympathetic, catecholamines), and decreased contractility (heart failure). Panel B: Sarcomere diagram showing stretch to optimal length (2.0 to 2.2 micrometers) improving actin-myosin overlap with too little or too much stretch reducing overlap. Panel C: Diagram showing stretch increases calcium sensitivity with same calcium transient producing greater force in stretched fiber. Panel D: Physiological example of increased venous return to RV leading to increased RV output, increased pulmonary return to LV, LV stretch, and automatic LV output increase to match.</image>

Preload

Preload refers to the stretch on the ventricular muscle fibers at the end of diastole, just before contraction begins. It is determined primarily by end-diastolic volume and is the starting condition from which the ventricle contracts. Clinically, preload can be estimated by measuring end-diastolic pressure or its surrogates.

Multiple factors determine preload. Venous return is the primary determinant—increased venous return increases ventricular filling and preload. Blood volume directly affects filling; volume expansion increases preload while volume depletion reduces it. Venous tone affects the distribution of blood between the capacitance vessels and the heart; venoconstriction shifts blood centrally and increases preload. Atrial contraction contributes 15 to 25 percent of ventricular filling, becoming increasingly important when ventricular compliance is reduced or heart rate is high. Body position affects venous return through gravitational effects—supine position increases preload compared to standing. Intrathoracic pressure influences venous return to the right heart; inspiration decreases intrathoracic pressure and increases right ventricular preload. Finally, ventricular compliance determines how much volume is achieved at any given filling pressure; reduced compliance means less filling at the same pressure.

Several factors reduce preload. Hemorrhage reduces blood volume and venous return. Diuretic therapy causes volume depletion. Venodilators such as nitroglycerin cause venous pooling, reducing central blood volume. Standing causes gravitational pooling of blood in the lower extremities. Positive pressure ventilation increases intrathoracic pressure and impedes venous return.

Preload is assessed clinically using various measurements. Central venous pressure (CVP), measured in the right atrium, estimates right ventricular preload. Pulmonary capillary wedge pressure (PCWP), measured by advancing a Swan-Ganz catheter until it wedges in a small pulmonary artery, estimates left atrial pressure and thus left ventricular preload. Echocardiography can directly measure left ventricular end-diastolic volume.

<image>Panel A: Heart with arrows showing venous return via venae cavae, blood volume represented by blood bag, and venous tone with smooth muscle constriction shifting blood centrally. Panel B: Atrial contraction contributing 25% to ventricular filling and body position comparison (supine with higher preload vs standing with lower preload from leg pooling). Panel C: Intrathoracic pressure with lung diagram showing inspiration decreasing pressure and ventricular compliance curves comparing normal vs stiff ventricle. Panel D: Clinical assessment methods showing CVP catheter in right atrium, Swan-Ganz catheter measuring PCWP, and echocardiogram showing LV chamber measurement.</image>

Afterload

Afterload represents the resistance that the ventricle must overcome to eject blood. More precisely, it is the wall stress (tension per unit area) in the ventricular wall during systole. According to the Law of Laplace, wall stress equals the product of pressure and radius divided by twice the wall thickness.

The primary determinant of left ventricular afterload is systemic vascular resistance (SVR), which is itself determined mainly by arteriolar tone. Arterial blood pressure represents the pressure the ventricle must overcome, so hypertension increases afterload. Aortic valve stenosis creates an additional resistance to ejection, substantially increasing afterload. Aortic compliance affects how much pressure rises for a given stroke volume—stiff arteries (as in aging or atherosclerosis) increase afterload. The ventricle itself contributes to afterload through the Laplace relationship: a dilated ventricle with larger radius has higher wall stress at any given pressure.

Afterload has important effects on cardiac performance. Increased afterload reduces stroke volume if contractility remains constant, because the ventricle cannot empty as completely against higher resistance. This is reflected in increased end-systolic volume. Increased afterload also increases myocardial oxygen consumption because the heart must work harder (generate higher wall stress) to eject blood. Chronic afterload elevation, as in systemic hypertension or aortic stenosis, leads to compensatory left ventricular hypertrophy—the ventricle thickens to normalize wall stress. While initially adaptive, this hypertrophy eventually leads to diastolic dysfunction and, ultimately, systolic failure.

Afterload reduction is a key therapeutic strategy in heart failure. Vasodilators such as ACE inhibitors, angiotensin receptor blockers, and hydralazine decrease systemic vascular resistance, making it easier for the ventricle to eject blood. This increases stroke volume and reduces end-systolic volume and wall stress.

<image>Panel A: Law of Laplace applied to left ventricle showing LV wall cross-section with parameters (P for pressure, r for radius, h for wall thickness) and equation Wall Stress = (P x r) / (2 x h). Panel B: Pressure-volume loops showing normal loop in black and increased afterload loop in red with higher peak pressure, increased ESV, and decreased SV. Panel C: Clinical conditions showing hypertension (elevated BP), aortic stenosis (narrowed valve with gradient), and dilated cardiomyopathy (enlarged LV with increased wall stress). Panel D: Compensatory response of concentric hypertrophy (thickened wall normalizing stress) and therapeutic vasodilators decreasing SVR and improving ejection.</image>

Contractility

Contractility, or inotropy, refers to the intrinsic ability of cardiac muscle to generate force, independent of preload and afterload. It represents a change in the performance of the heart that cannot be explained by changes in loading conditions—a shift of the entire Frank-Starling curve rather than movement along it.

Assessing contractility is challenging because most measures are influenced by loading conditions. The maximum rate of pressure rise in the left ventricle (dP/dt max) is commonly used and reflects the velocity of contraction during isovolumetric contraction, when volume is constant. Ejection fraction is widely used clinically but is affected by both preload and afterload. The end-systolic pressure-volume relationship (ESPVR) provides a load-independent measure—the slope of this relationship (end-systolic elastance) reflects contractile state. A steeper ESPVR indicates enhanced contractility.

Numerous factors increase contractility. Sympathetic stimulation through beta-1 adrenergic receptors is the most important physiological positive inotrope. The signaling cascade involves norepinephrine binding to beta-1 receptors, activating the stimulatory G protein, increasing cyclic AMP production by adenylyl cyclase, and activating protein kinase A. PKA phosphorylates multiple targets: L-type calcium channels (increasing calcium influx), ryanodine receptors (enhancing calcium-induced calcium release), phospholamban (disinhibiting SERCA and accelerating calcium reuptake), and troponin I (increasing cross-bridge cycling rate). Circulating catecholamines (epinephrine) and positive inotropic drugs such as dobutamine work through the same pathway. Digitalis glycosides increase contractility by inhibiting the sodium-potassium ATPase, leading to sodium accumulation and reduced calcium extrusion via the sodium-calcium exchanger. Increased heart rate itself increases contractility through the staircase effect (Bowditch effect) due to accumulation of intracellular calcium. Thyroid hormone increases myosin ATPase activity and beta-receptor sensitivity.

Factors decreasing contractility include parasympathetic stimulation (primarily affecting atrial contractility through reduced calcium current), beta-blockers (blocking beta-1 receptors), heart failure (intrinsic myocyte dysfunction from multiple mechanisms), hypoxia and ischemia (reduced ATP production), acidosis (reduced calcium sensitivity), and calcium channel blockers.

<image>Panel A: Beta-1 adrenergic signaling cascade showing norepinephrine binding to beta-1 receptor, activating Gs protein, adenylyl cyclase producing cAMP, and PKA activation. Panel B: PKA phosphorylating four targets: L-type Ca2+ channel (enhanced entry), RyR2 (enhanced SR release), phospholamban (SERCA disinhibition), and troponin I (faster cycling) resulting in increased force and faster contraction/relaxation. Panel C: Family of Frank-Starling curves showing baseline (blue), increased contractility (green, shifted up/left with catecholamines, digitalis, thyroid hormone), and decreased contractility (red, shifted down/right with heart failure, beta-blockers, acidosis). Panel D: ESPVR diagram showing slope increase with enhanced contractility and demonstration that same preload produces greater stroke volume.</image>

Neural Regulation of Cardiac Output

The autonomic nervous system provides moment-to-moment regulation of cardiac output through both sympathetic and parasympathetic divisions.

Sympathetic innervation to the heart comes from the thoracic spinal cord (T1-T4), synapses in the cervical and upper thoracic sympathetic ganglia, and reaches the heart via cardiac nerves. Sympathetic fibers densely innervate the SA node, AV node, atria, and ventricles. The neurotransmitter norepinephrine acts primarily on beta-1 adrenergic receptors.

Sympathetic stimulation produces four positive effects on the heart. Positive chronotropy increases heart rate by accelerating phase 4 depolarization in pacemaker cells through enhanced funny current and L-type calcium current. Positive inotropy increases contractility through the cAMP-PKA pathway, enhancing calcium handling and increasing force generation. Positive dromotropy accelerates conduction, particularly through the AV node, by increasing calcium current in nodal cells. Positive lusitropy accelerates relaxation by phosphorylating phospholamban and troponin I, speeding calcium reuptake and cross-bridge detachment.

Parasympathetic innervation reaches the heart through the vagus nerve (cranial nerve X). Preganglionic fibers synapse in ganglia located within the cardiac plexus or in the atrial walls themselves. Short postganglionic fibers release acetylcholine, which acts on M2 muscarinic receptors. Vagal innervation is dense in the SA node and AV node but sparse in the ventricles.

Parasympathetic effects are essentially opposite to sympathetic effects. Negative chronotropy decreases heart rate by hyperpolarizing pacemaker cells through acetylcholine-activated potassium channels (IKACh) and by reducing the funny current. Negative dromotropy slows conduction through the AV node. Parasympathetic effects on ventricular contractility are minimal due to sparse innervation.

At rest, parasympathetic (vagal) tone predominates. This is demonstrated by the fact that resting heart rate (approximately 70 beats per minute) is lower than the intrinsic SA node rate (approximately 100 beats per minute). Blocking vagal effects with atropine produces tachycardia, while blocking sympathetic effects with propranolol produces only modest bradycardia from the resting state.

<image>Panel A: Heart with sympathetic pathway (green) from T1-T4 spinal segments through cervical and thoracic ganglia to SA node, AV node, atria, and ventricles, and parasympathetic pathway (blue) via vagus nerve to SA and AV nodes with sparse ventricular innervation. Panel B: Effects table showing sympathetic (beta-1): +chronotropy, +inotropy, +dromotropy, +lusitropy; parasympathetic (M2): -chronotropy, -dromotropy, minimal ventricular effect. Panel C: Molecular mechanisms in pacemaker cells showing sympathetic activation (increased cAMP, enhanced If and ICaL, steeper phase 4, increased rate) and parasympathetic activation (IKACh channels, hyperpolarization, reduced phase 4, decreased rate). Panel D: Bar graph comparing resting heart rate (70 bpm) to intrinsic SA node rate (100 bpm) with vagal tone responsible for difference.</image>

Hormonal Regulation

Beyond neural control, circulating hormones modulate cardiac output on a somewhat slower timescale.

Catecholamines, primarily epinephrine released from the adrenal medulla, supplement sympathetic neural effects. Epinephrine acts on the same beta-1 receptors as norepinephrine, increasing heart rate and contractility. At low concentrations, epinephrine also activates beta-2 receptors in skeletal muscle vasculature, causing vasodilation that reduces afterload and supports exercise hemodynamics. At high concentrations, alpha-1 receptor activation predominates, causing vasoconstriction.

Thyroid hormones have profound cardiovascular effects. Hyperthyroidism increases heart rate by upregulating beta-adrenergic receptors and directly affecting pacemaker channels. It increases contractility by increasing the expression of faster myosin heavy chain isoforms and enhancing calcium handling. The overall effect is markedly increased cardiac output. Hypothyroidism produces the opposite effects—bradycardia and reduced contractility.

The renin-angiotensin-aldosterone system (RAAS) affects cardiac output primarily through its effects on blood volume and vascular resistance. Angiotensin II increases afterload through vasoconstriction and increases preload by stimulating aldosterone release (causing sodium and water retention) and by enhancing thirst and ADH release. Chronically, angiotensin II promotes adverse cardiac remodeling.

Antidiuretic hormone (vasopressin) has dual effects. Through V2 receptors in the renal collecting duct, it promotes water retention, expanding blood volume and increasing preload. Through V1 receptors on vascular smooth muscle, it causes vasoconstriction, increasing afterload.

Atrial and brain natriuretic peptides (ANP and BNP) are released in response to atrial and ventricular stretch, respectively. They promote natriuresis and diuresis, reducing blood volume and preload. They also cause vasodilation, reducing afterload. BNP levels are used clinically as biomarkers of heart failure.

<image>Panel A: Catecholamine effects showing adrenal medulla releasing epinephrine to heart (beta-1 receptors increasing HR and contractility) and blood vessels (dose-dependent beta-2 vasodilation at low doses, alpha-1 vasoconstriction at high doses). Panel B: Thyroid effects showing T3/T4 increasing beta-receptor expression and myosin ATPase activity in heart resulting in increased HR and contractility. Panel C: RAAS schematic showing kidney releasing renin, angiotensinogen conversion to angiotensin I then angiotensin II by ACE, with effects on vasoconstriction, aldosterone, ADH, and thirst. Panel D: ANP/BNP released from stretched atria/ventricles causing natriuresis, diuresis, and vasodilation reducing cardiac work with arrows indicating net effects on cardiac output.</image>

Venous Return and Cardiac Function Curves

A complete understanding of cardiac output regulation requires considering the interaction between the heart as a pump and the circulation as the source of its input. Guyton's analysis of cardiac output regulation elegantly demonstrated this interaction through the superimposition of cardiac function and venous return curves.

The venous return curve describes the relationship between right atrial pressure (the back-pressure against which venous blood returns) and venous return. As right atrial pressure decreases, venous return increases because the pressure gradient driving blood from the peripheral veins to the right atrium increases. However, at very low right atrial pressures (around 0 mmHg), the great veins begin to collapse at the thoracic inlet, limiting further increases in venous return. The x-intercept of this curve, where venous return would be zero, represents the mean systemic filling pressure (MSFP)—the pressure throughout the circulation when the heart is stopped and blood redistributes. MSFP is normally about 7 mmHg and reflects the stressed volume in the circulatory system.

Multiple factors shift the venous return curve. Increased blood volume or venoconstriction increases MSFP and shifts the curve rightward and upward, allowing greater venous return at any right atrial pressure. Decreased blood volume or venodilation has the opposite effect. Decreased arteriolar resistance increases the slope of the curve by reducing the resistance to blood flow from arteries to veins.

The cardiac function curve (essentially a Frank-Starling curve plotted with right atrial pressure on the x-axis) describes the heart's output at various filling pressures. As right atrial pressure increases, cardiac output increases.

When superimposed on the same axes, the intersection of the cardiac function and venous return curves defines the operating point—the actual cardiac output and right atrial pressure at equilibrium. Any change in either curve will shift the operating point. For example, sympathetic stimulation shifts the cardiac function curve upward, increasing cardiac output while reducing right atrial pressure. Volume infusion shifts the venous return curve rightward, increasing both cardiac output and right atrial pressure.

<image>Panel A: Guyton diagram axes with right atrial pressure (mmHg, -4 to 12) on x-axis and cardiac output/venous return (L/min, 0 to 15) on y-axis showing venous return curve (blue) sloping downward reaching zero at MSFP (~7 mmHg). Panel B: Cardiac function curve (red) sloping upward with plateau at high RAP, intersection with VR curve marking operating point (CO ~5 L/min, RAP ~2 mmHg). Panel C: Rightward VR curve shift (dashed blue, increased blood volume or venoconstriction) resulting in new operating point with higher CO and higher RAP. Panel D: Upward CF curve shift (dashed red, increased contractility) resulting in higher CO but lower RAP with arrows showing shift directions and operating point changes.</image>

Clinical Applications

Understanding cardiac output regulation illuminates the hemodynamic changes that occur in exercise, heart failure, and shock states.

The exercise response demonstrates the integrated function of all regulatory mechanisms. Heart rate increases substantially, from approximately 70 beats per minute at rest to 180 to 200 beats per minute during maximal exercise, primarily through sympathetic activation and parasympathetic withdrawal. Stroke volume increases by about 50 percent through enhanced contractility (sympathetic stimulation) and optimized preload (the muscle pump and venoconstriction increase venous return). The net result is a fourfold to fivefold increase in cardiac output, from 5 liters per minute to 20 to 25 liters per minute. Simultaneously, systemic vascular resistance decreases due to vasodilation in exercising skeletal muscle, allowing the increased cardiac output to be delivered where it is needed.

Heart failure represents a state of inadequate cardiac output to meet metabolic demands. Contractility is reduced, shifting the Frank-Starling curve downward. The heart compensates by operating at higher filling pressures, but the curve is flattened, so increases in preload produce smaller increases in output. The failing heart cannot augment output appropriately during exercise. Neurohormonal activation (sympathetic system, RAAS) initially helps maintain blood pressure but eventually proves maladaptive, causing vasoconstriction (increased afterload) and volume retention (congestion). Treatment targets these abnormalities: diuretics reduce congestion by lowering preload, vasodilators reduce afterload, and ACE inhibitors and beta-blockers interrupt maladaptive neurohormonal activation.

Shock states illustrate different hemodynamic patterns. Cardiogenic shock, from pump failure, produces decreased cardiac output, increased systemic vascular resistance (compensatory vasoconstriction), and elevated filling pressures (preload). Hypovolemic shock, from blood or fluid loss, produces decreased cardiac output, increased systemic vascular resistance, and decreased filling pressures. Distributive shock, such as septic shock, produces vasodilation that decreases systemic vascular resistance; cardiac output may initially be increased (hyperdynamic phase) but eventually falls as cardiac dysfunction develops. Treatment is directed at the underlying cause and at correcting the hemodynamic abnormalities—fluid resuscitation for hypovolemic shock, vasopressors for distributive shock, and inotropic support for cardiogenic shock.

<image>Panel A: Exercise response graph showing progressive increase in HR (70 to 200 bpm), SV (70 to 100 mL), and CO (5 to 20 L/min) with intensity, illustrating sympathetic activation increasing HR and contractility, muscle pump increasing venous return, and vasodilation decreasing SVR. Panel B: Heart failure Frank-Starling curve comparison showing normal curve (blue, steep) versus heart failure curve (red, flattened and shifted down) with operating points showing higher filling pressure required for lower cardiac output. Panel C: Treatment arrows showing diuretics shifting operating point left (reduce preload) and ACE inhibitors/vasodilators and beta-blockers improving the curve. Panel D: Shock types table comparing cardiogenic (CO down, SVR up, Preload up), hypovolemic (CO down, SVR up, Preload down), and distributive (CO variable, SVR down) with hemodynamic profiles and treatment strategies.</image>

Summary

Cardiac output, calculated as heart rate times stroke volume, normally equals approximately 5 liters per minute at rest and can increase fourfold to fivefold during maximal exercise. The Fick principle (CO = VO₂ / A-V O₂ difference) provides the gold standard measurement, while thermodilution and echocardiography are widely used clinically.

The Frank-Starling mechanism is the intrinsic property by which increased preload leads to increased stroke volume, ensuring that the heart pumps out whatever it receives. Preload is determined by venous return, blood volume, venous tone, and body position. Afterload represents the resistance to ejection, primarily determined by systemic vascular resistance. Contractility is the intrinsic force-generating ability, enhanced by sympathetic stimulation and reduced in heart failure.

Neural control involves sympathetic activation (increasing heart rate and contractility via beta-1 receptors) and parasympathetic activation (decreasing heart rate via M2 receptors). Hormonal control involves catecholamines, thyroid hormones, the renin-angiotensin system, and natriuretic peptides.

The Guyton diagram shows that cardiac output is determined by the intersection of the cardiac function curve and the venous return curve, reflecting the interplay between the heart as a pump and the circulation as its source.

Key Terms

This content is subject to the MIT License. © 2024–2026 Hibbert School of Medicine.

Read this lecture as Markdown